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segment elevation myocardial infarction
(METOCARD-CNIC randomized clinical trial
substudy)
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Javier Sánchez-González9, Chiara Bucciarelli-Ducci10, Nina Ajmone Marsan1, Zlatko Fras3, Jeroen J. Bax1,
Valentin Fuster4,7, Borja Ibáñez4,5,11 and Victoria Delgado1*
Abstract
Background: We aimed to evaluate the effect of early intravenous metoprolol treatment, microvascular obstruction
(MVO), intramyocardial hemorrhage (IMH) and adverse left ventricular (LV) remodeling on the evolution of infarct
and remote zone circumferential strain after acute anterior ST-segment elevation myocardial infarction (STEMI) with
feature-tracking cardiovascular magnetic resonance (CMR).
Methods: A total of 191 patients with acute anterior STEMI enrolled in the METOCARD-CNIC randomized clinical
trial were evaluated. LV infarct zone and remote zone circumferential strain were measured with feature-tracking
CMR at 1 week and 6 months after STEMI.
Results: In the overall population, the infarct zone circumferential strain significantly improved from 1 week to 6
months after STEMI (− 8.6 ± 9.0% to − 14.5 ± 8.0%; P < 0.001), while no changes in the remote zone strain were
observed (− 19.5 ± 5.9% to − 19.2 ± 3.9%; P = 0.466). Patients who received early intravenous metoprolol had
significantly more preserved infarct zone circumferential strain compared to the controls at 1 week (P = 0.038) and
at 6 months (P = 0.033) after STEMI, while no differences in remote zone strain were observed. The infarct zone
circumferential strain was significantly impaired in patients with MVO and IMH compared to those without (P <
0.001 at 1 week and 6 months), however it improved between both time points regardless of the presence of MVO
or IMH (P < 0.001). In patients who developed adverse LV remodeling (defined as ≥ 20% increase in LV end-diastolic
volume) remote zone circumferential strain worsened between 1 week and 6months after STEMI (P = 0.036), while
in the absence of adverse LV remodeling no significant changes in remote zone strain were observed.
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Conclusions: Regional LV circumferential strain with feature-tracking CMR allowed comprehensive evaluation of the
sequelae of an acute STEMI treated with primary percutaneous coronary intervention and demonstrated long-
lasting cardioprotective effects of early intravenous metoprolol.
Trial registration: ClinicalTrials.gov, NCT01311700. Registered 8 March 2011 - Retrospectively registered.
Keywords: Feature-tracking cardiovascular magnetic resonance, ST-segment elevation myocardial infarction,
Intravenous metoprolol, Microvascular obstruction, Intramyocardial hemorrhage, Left ventricular remodeling
Background
Cardiovascular magnetic resonance (CMR) is a power-
ful noninvasive clinical and research imaging tool for
the assessment of the sequelae of an acute myocardial
infarction [1]. Within a single scan, assessment of left
ventricular (LV) volumes and function, myocardial
edema, infarct extent and transmurality, and micro-
vascular damage can be performed. Traditional pa-
rameters such as LV volumes and LV ejection
fraction and CMR-specific parameters, such as infarct
size with late gadolinium enhancement (LGE), pres-
ence of microvascular obstruction (MVO) and intra-
myocardial hemorrhage (IMH) have demonstrated to
predict post-infarction LV remodeling and clinical
outcome [2–4]. Recently, feature-tracking CMR has
been shown to allow for multidirectional myocardial
strain assessment from standard CMR cine images
without the need for specialized pulse sequences and
additional scanning time [5, 6]. Global LV longitu-
dinal strain and circumferential strain with feature-
tracking CMR have provided important prognostic in-
formation after myocardial infarction [7, 8]. On the
other hand, regional LV deformation has been mostly
studied in small single-center studies with different
CMR tissue tracking techniques, such as myocardial
tagging, strain encoded (SENC) imaging, displacement
encoding with stimulated echoes (DENSE) imaging or
feature-tracking [9–15]. However, the evolution of LV
strain after a ST-segment elevation myocardial infarc-
tion (STEMI) within infarcted and remote myocar-
dium has not yet been investigated with feature-
tracking CMR.
Accordingly, the present sub-analysis of the Effect
of Metoprolol in Cardioprotection During an Acute
Myocardial Infarction (METOCARD-CNIC) trial [16]
evaluated the changes in regional LV peak circumfer-
ential strain after STEMI using feature-tracking CMR.
The infarct zone and the remote zone circumferential
strain were assessed at 1 week and 6 months after
STEMI and the effects of the treatment arm (meto-
prolol versus control), MVO, IMH and adverse LV
remodeling on the evolution of infarct and remote
zone strain were investigated.
Methods
Patient population
The present study included patients who were enrolled
in the METOCARD-CNIC trial [16]. Briefly, the multi-
center randomized METOCARD-CNIC clinical trial re-
cruited patients with first anterior STEMI undergoing
primary percutaneous coronary intervention (PCI). A
total of 270 patients were randomized to receive up to
15mg intravenous metoprolol before reperfusion versus
conventional therapy. Of the initial population, 202 pa-
tients underwent CMR at 1 week (5 to 7 days) and at 6
months after STEMI. Patients receiving intravenous
metoprolol and controls were comparable in terms of
demographic characteristics, cardiovascular risk profile,
procedural characteristics and discharge medication, as
previously described [16–18]. Infarct zone and remote
zone circumferential strain were evaluated with feature-
tracking CMR at 1 week and 6months after STEMI.
Moreover, the effects of the treatment arm (metoprolol
versus control), MVO, IMH and adverse LV remodeling
on infarct and remote zone strain were investigated.
The study was approved by the ethical committees
and institutional review boards at each participating cen-
ter. All eligible patients gave written informed consent.
Cardiovascular magnetic resonance
The CMR protocol has been described in detail else-
where [19]. Data acquisition was performed with 1.5 and
3 T CMR scanners at 1 week and 6months after STEMI.
LV long-axis views and a stack of contiguous short-axis
slices to cover the whole LV were acquired with bal-
anced steady-state free precession (bSSFP) functional
cine imaging. Data acquisition parameters were: voxel
size 1.6 × 2mm, slice thickness 8 mm, gap 0 mm, cardiac
phases 25–30, TR 3.5, TE 1.7, flip angle 40, SENSE 1.5,
averages 1, FOV 360 × 360mm. Subsequently, edema
imaging was performed using a T2-weighted short tau
inversion recovery (STIR) sequence, followed by LGE
imaging with segmented inversion recovery gradient
echo sequence, acquired 10–15min after intravenous
gadolinium contrast agent.
CMR parameters were analyzed with dedicated soft-
ware (QMass MR 7.5; Medis, Leiden, the Netherlands).
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LV volumes and function were determined from
bSSFP cine short-axis image dataset. Infarct size was
defined as the percent of LGE with full-width-half-
maximum technique on delayed enhancement images.
The presence of MVO, defined as hypointense areas
within the hyperenhanced infarct zone, was evaluated
by visual assessment on 1-week CMR. Areas with
MVO were included in the infarct size. The presence
of IMH, defined as hypointense areas within the
brighter edematous zone on T2-STIR images, was
evaluated by visual assessment on 1-week CMR.
Feature-tracking cardiovascular magnetic resonance
analysis
Feature-tracking CMR analysis was performed with ded-
icated software (cvi42 v5.3, Circle Cardiovascular Im-
aging, Calgary, Canada). First, the LV endo- and
epicardium were delineated in contiguous short-axis
slices and the anterior right ventricular insertion point
was defined. The most basal slice(s), if the aortic valve
plane was present in systolic frames, and most apical sli-
ces(s), if myocardial borders were unclear, were ex-
cluded. In addition, the mitral annulus and the LV apex
were defined in long-axis slices to allow for automated
LV segmentation. The outlined myocardium borders
were automatically tracked throughout the cardiac cycle
with fully automated feature-tracking analysis. The qual-
ity of the myocardium tracking was visually evaluated
with manual adjustments of the contours if necessary (<
5% of cases). Segmental peak circumferential strain
values were obtained according to the 16-segment model
of LV [20]. Twenty randomly selected CMR scans were
chosen (> 4 weeks after the primary analysis) for the as-
sessment of intra- and inter-observer reproducibility of
the segmental circumferential strain measurements.
Definition of infarct zone and remote zone myocardium
The LV myocardium was divided into the infarct zone
and the remote zone regions. Taking into consideration
that the METOCARD-CNIC trial included a homoge-
neous population of patients with anterior STEMI and
that in > 98% of patients undergoing CMR the culprit le-
sion was in the left anterior descending coronary artery
(LAD) [16], the infarct zone was defined as the LAD
perfusion territory. The segmental coronary artery distri-
bution model from the American Society of Echocardi-
ography and the European Association of Cardiovascular
Imaging guidelines was used [20]. In addition, according
to previous studies with CMR and single-photon emis-
sion computed tomography showing that the apical seg-
ments most commonly correspond to the LAD
perfusion territory, all apical segments were included in
the infarct zone [21, 22]. Importantly, the proximal and
the mid-distal LAD infarctions were defined differently
[23]. When the culprit coronary artery lesion was in the
proximal LAD, the infarct zone included the segments
1–2, 7–8 and 13–16 and the rest of LV myocardium
was defined as the remote zone (Fig. 1a). If the cul-
prit lesion was in the mid or distal LAD, the infarct
zone included the segments 7–8 and 13–16 (the basal
anterior and anteroseptal segments were not in-
cluded), while the rest of LV myocardium was defined
as the remote zone (Fig. 1b).
Study endpoints
The objective of the present analysis was to study the
evolution of LV circumferential strain within the infarct
zone and the remote zone myocardium in patients with
anterior STEMI treated with primary PCI and receiving
early intravenous metoprolol versus patients treated with
standard of care. Furthermore, the impact of MVO and
IMH on infarct and remote zone circumferential strain
was investigated. Finally, regional circumferential strain
was investigated in patients who developed adverse LV
remodeling. Adverse LV remodeling was defined as
≥20% increase in LV end-diastolic volume at 6 months
compared to the LV end-diastolic volume at 1 week after
STEMI [24]. For each patient population (metoprolol vs.
control treatment; presence vs. absence of MVO and
IMH; presence vs. absence of adverse LV remodeling)
the infarct and remote zone strain values were compared
at 1 week and at 6 months after STEMI.
Statistical analysis
Continuous variables are presented as mean ± standard
deviation. Comparisons between 1-week and 6-month
infarct and remote zone circumferential strain were per-
formed using paired samples t-test. Comparisons be-
tween infarct and remote zone circumferential strain
among different groups of patients (with respect to the
randomization treatment, the presence of MVO, IMH
and adverse LV remodeling) were performed using inde-
pendent samples t-test. The intra- and inter-observer
agreement for the segmental circumferential LV strain
measurements were assessed with intraclass correlation
coefficients. A two-sided P-value of < 0.05 was statisti-
cally significant and excellent agreement was defined as
an intraclass correlation coefficient > 0.9. All statistical
analyses were performed with SPSS (v 23, Statistical
Package for the Social Sciences, International Business
Machines, Inc., Armonk, New York, USA).
Results
Of 202 patients with 1-week and 6-month CMR scans, 6
patients were excluded due to a non-LAD infarction (3
patients in the metoprolol group and 3 patients in the
control group) [16]. In addition, feature-tracking could
not be performed in 5 patients (1 in the early metoprolol
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group and 4 in the control group) due to CMR image
acquisition artefacts. Finally, LV circumferential strain
analysis was feasible in 191 patients (early metoprolol
group: N = 97; control group: N = 94) and they formed
the population of the present analysis. A proximal LAD
infarct was present in 60 patients and a mid-distal LAD
infarct was present in 131 patients, with no statistically
significant differences between both treatment arms. Pa-
tients demographics, cardiovascular risk factors, clinical
status at recruitment, procedural characteristics and
CMR parameters at 1 week and 6months after STEMI
of the overall population and of the randomization treat-
ment (metoprolol vs control) groups are presented in
the Additional file 1: Table 1, and do not differ from
those previously published [16–18].
Evolution of infarct and remote zone circumferential
strain
In the overall population the infarct zone strain signifi-
cantly improved from 1 week to 6 months after STEMI
(from − 8.6% to − 14.5%, mean difference (MD) -5.9%;
95% confidence interval (CI) -6.9 to − 4.8; P < 0.001),
while no significant changes in the remote zone strain
were observed (from − 19.5% to − 19.2%, MD 0.3%; 95%
CI − 0.5 to 1.1; P = 0.466).
The effect of early intravenous metoprolol on infarct and
remote zone circumferential strain
One week after STEMI, patients who received early
intravenous metoprolol had more preserved infarct zone
strain (P = 0.038) compared to the control group, while
no significant differences in the remote zone strain were
observed (P = 0.589). The infarct zone strain significantly
improved from 1 week to 6 months after STEMI in both
groups of patients (P < 0.001), while the remote zone
strain remained stable (P > 0.05). At 6 months after
STEMI, the infarct zone strain remained significantly
more preserved among patients receiving early intraven-
ous metoprolol compared to the controls (P = 0.033),
while no significant differences in the remote zone strain
between both treatment arms were observed (P = 0.879).
The effects of early intravenous metoprolol on infarct
and remote zone strain are summarized in Table 1 and
Fig. 2. In addition, two patient examples, one receiving
early intravenous metoprolol and one receiving standard
care, are shown in Figs. 3 and 4.
Fig. 1 Definition of the infarct and remote zone myocardium. a, In case the culprit coronary artery lesion was in the proximal left anterior
descending coronary artery (LAD), the infarct zone was defined according to the 16-segment model of the left ventricle (LV) with the segments
1–2, 7–8 and 13–16 and the rest of the LV myocardium was defined as the remote zone. b, If the culprit lesion was found in mid or distal LAD,
the infarct zone included segments 7–8 and 13–16 and the rest of LV myocardium was defined as the remote zone. LAD, left anterior
descending; LCX, left circumflex; LM, left main
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The effect of MVO and IMH on infarct and remote zone
circumferential strain
The infarct zone strain was significantly more im-
paired in patients with MVO or IMH, both at 1 week
and at 6 months after STEMI (P < 0.001). In contrast,
there were no differences in remote zone strain be-
tween the 2 groups at both time points (P > 0.05). Im-
portantly, the infarct zone strain improved from 1
week to 6 months regardless of the presence of MVO
and IMH (P < 0.001) and remote zone strain remained
stable in all groups of patients (P > 0.05). The effects
of MVO and IMH on infarct and remote zone strain
are summarized in Tables 2 and 3. In addition, two
patient examples, one with MVO and IMH and one
without, are shown in Figs. 3 and 4.
The effect of adverse LV remodeling on infarct and
remote zone circumferential strain
There were no statistically significant differences in the
infarct zone strain and remote zone strain between pa-
tients who did and those who did not develop adverse
LV remodeling, both at 1 week and at 6 months after
STEMI (P > 0.05). Furthermore, in both patient popula-
tions the infarct zone strain improved between 1 week
and 6months after STEMI (P < 0.001). However, in pa-
tients who developed adverse LV remodeling remote
zone strain worsened between 1 week and 6months after
STEMI (P = 0.036), while in the absence of adverse LV
remodeling no significant changes in remote zone strain
were observed (P = 0.991). The effects of adverse LV re-
modeling on infarct and remote zone strain are
Fig. 2 The infarct zone and the remote zone strain after ST-segment elevation myocardial infarction (STEMI) in patients
receiving early intravenous metoprolol versus controls. Left ventricular (LV) infarct zone and remote zone strains are schematically
presented with the mean values in patients receiving early intravenous metoprolol and in patients receiving conventional treatment at 1 week
and at 6 months after STEMI. LV was split into the infarct and the remote zone as explained in Fig. 1. In order to schematically present different
infarct territories in patients with proximal left anterior descending coronary artery (LAD) coronary artery infarcts and mid-distal LAD infarcts,
fainter colors were used to paint the basal anterior and anteroseptal segments, signifying that these segments were either included in the infarct
zone (proximal LAD infarcts) or remote zone (mid-distal LAD infarcts) strain analysis. Comparisons between 1-week and 6-month strains are
graphically represented on the right-hand side using the same model, with corresponding P-values shown separately for the infarct and remote
zone strain analysis. In addition, comparisons between the metoprolol and the control group are shown in the bottom row
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summarized in Table 4. In addition, two patient exam-
ples, one with adverse LV remodeling and one without,
are shown in Figs. 3 and 4.
Reproducibility of segmental circumferential left
ventricular strain measurements
Excellent intra- and inter-observer variabilities for the
feature-tracking CMR analysis of the segmental circum-
ferential strain were obtained. The intra-observer intra-
class correlation coefficient (95% CI) was 0.925 (0.906–
0.940) and the inter-observer intraclass correlation coef-
ficient (95% CI) was 0.907 (0.884–0.926).
Discussion
The present study shows that the infarct zone circumfer-
ential strain improved while the remote zone circumfer-
ential strain remained stable between 1 week and 6
months after STEMI. Early intravenous metoprolol had
a long-lasting cardioprotective effect on the infarct zone
circumferential strain and no significant effect on the re-
mote zone circumferential strain. The infarct zone cir-
cumferential strain was significantly impaired in patients
with MVO and IMH, but it improved between 1 week
and 6months after STEMI regardless of the presence of
MVO or IMH. In patients with adverse LV remodeling,
defined as ≥20% increase in LV end-diastolic volume,
the infarct zone circumferential strain improved but the
remote zone circumferential strain worsened between 1
week and 6months after STEMI.
Evolution of the infarct and remote zone circumferential
strain
Several studies have used CMR to monitor the evolution
of regional LV strain after reperfused myocardial infarc-
tion [9–13]. Kidambi et al [9] compared changes in cir-
cumferential strain with myocardial tagging in the
infarct and remote myocardium in 39 patients who
underwent CMR at 2, 30 and 90 days after STEMI. A
gradual improvement of the infarct zone circumferential
strain was observed (− 10.2, − 16.0% and − 18.6% at days
2, 30 and 90, respectively, P < 0.001 for 30-day versus 2-
day strain and P = 0.04 for 90-day versus 30-day strain)
while no significant dynamics in the remote myocardium
circumferential strain was observed (− 22.6, − 24.0%, −
Fig. 3 A patient with a proximal LAD infarct receiving standard STEMI treatment. a, balanced steady state free precession (bSSFP) end-
diastolic images with endo- and epi-cardial contours. The patient developed adverse left ventricular (LV) remodeling (defined as ≥ 20% increase
in LV end-diastolic volume (LVEDV) and had a slight reduction in LV ejection fraction (LVEF) at 6 months after STEMI. b, T2-weighted short tau
inversion recovery (STIR) images, showing the presence of edema (white arrows) and intramyocardial hemorrhage (IMH) (yellow arrowheads) at 1-
week after STEMI. c, late gadolinium enhancement (LGE) images, showing the presence of acute ischemic injury (white arrows) with
microvascular obstruction (MVO, yellow arrowheads) at 1 week after STEMI and infarct scar (white arrows) at 6-months. d, end-systolic bSSFP
images with feature-tracking circumferential LV strain overlay. At 6 months the infarct zone circumferential strain improved despite the presence
of a huge infarct with IMH and MVO in the acute phase, while the remote zone strain slightly declined bSSFP, balanced steady state free
precession; ED, end-diastolic; ES, end-systolic; IMH, intramyocardial hemorrhage; LAD, left anterior descending coronary artery, LGE, late
gadolinium enhancement; LV, left ventricular; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; MVO,
microvascular obstruction; SSFP, steady-state free precession; STEMI, ST-segment elevation myocardial infarction; STIR, short tau inversion recovery.
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24.1% at days 2, 30 and 90, P = 0.17 for 90-day versus 2-
day strain). Moreover, Gerber et al [11] studied regional
circumferential strain with myocardial tagging in 20 pa-
tients after myocardial infarction. Myocardial strain im-
proved between day 4 and 7months in infarcted
segments, with no changes observed in the remote
myocardium.
Similar to the reported literature, our results demon-
strate an improvement in the infarct zone circumferen-
tial strain and no significant changes in the remote zone
circumferential strain between the acute (1 week) and
chronic stage (6 months) of STEMI. However, the
present study included a much larger, homogeneous
group of patients with anterior STEMI prospectively in-
cluded in the multi-center randomized controlled clin-
ical METOCARD-CNIC trial [16]. In addition, while
other authors have employed different CMR tissue
tracking techniques like myocardial tagging, SENC or
DENSE imaging in the present analysis LV circumferen-
tial strain was evaluated with feature-tracking CMR.
The effect of early intravenous metoprolol on infarct and
remote zone circumferential strain
Early intravenous metoprolol has been associated with
improved short-term and long-term outcomes in the
METOCARD-CNIC trial [16, 17]. Patients who received
intravenous metoprolol prior to primary PCI had signifi-
cantly reduced infarct size 1 week after STEMI and had
more preserved LVEF at 1 week and at 6 months after
STEMI. In addition, we have previously shown that pa-
tients pre-treated with intravenous metoprolol had more
preserved global circumferential strain at 1 week after
Fig. 4 A patient with a mid-LAD infarct receiving early intravenous metoprolol. a, bSSFP end-diastolic images with endo- and epi-cardial
contours. The LV volumes remained stable and the LVEF increased at 6 months after STEMI. b, T2-STIR images showing the presence of edema
(white arrows) at 1-week after STEMI. c, LGE images showing the presence of acute ischemic injury/infarct scar (black arrows) at 1 week/6-months
after STEMI. d, end-systolic bSSFP images with feature-tracking circumferential LV strain overlay. At 6 months the infarct zone circumferential strain
improved while the remote zone strain remained stableThe same abbreviations were used as in Fig. 3
Table 2 The effect of microvascular obstruction (MVO) on infarct and remote zone strain
Infarct zone circumferential strain (%) Remote zone circumferential strain (%)
1 week 6 months MD [95% CI] P-value* 1 week 6 months MD [95% CI] P-value*
MVO (N = 117) − 5.1 ± 8.8 −11.2 ± 7.8 −6.2 [− 7.7 to − 4.7] < 0.001 − 19.3 ± 7.0 − 19.2 ± 3.8 0.1 [− 1.0 to 1.3] 0.828
No MVO (N = 73) −14.2 ± 6.1 − 19.5 ± 5.1 − 5.3 [− 6.5 to − 4.1] < 0.001 − 19.7 ± 3.4 −19.2 ± 4.2 0.5 [− 0.5 to 1.5] 0.313
MD [95% CI] 9.2 [6.9 to 11.5] 8.3 [6.5 to 10.2] 0.4 [−1.4 to 2.1] 0.0 [−1.2 to 1.1]
P-value† < 0.001 < 0.001 0.677 0.981
CI confidence interval, MD mean difference, MVO microvascular obstruction
*the P-values for the strain difference between 6months and 1 week
†the P-values for the strain difference between the group
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STEMI, while at 6 months the differences were not sig-
nificant [18]. However, the present study demonstrates
that the infarct zone circumferential strain was more
preserved among patients receiving early intravenous
metoprolol, both at 1 week and at 6 months after
STEMI. This is a very important finding, especially in
the view that the differences between the treatment arms
in global circumferential strain at 6 months were nonsig-
nificant, underscoring the long-lasting cardioprotective
effects of early intravenous metoprolol.
Interestingly, no differences in remote zone circumferential
strain were found between patients receiving early intraven-
ous metoprolol and controls. Recently, a slight progressive
increase in T2 relaxation time of the remote myocardium
has been reported in patients during the first week after
STEMI, implying a mild degree of edema of the remote
myocardium [25]. Since LV strain is closely associated with
post-myocardial infarction edema [9], we may have expected
to observe more preserved remote LV circumferential strain
in the early intravenous metoprolol group 1week after
STEMI. However, our results imply that the beneficial cardi-
oprotective effects of early intravenous metoprolol were
largely confined to the infarct zone myocardium.
The effect of microvascular obstruction and
intramyocardial hemorrhage on infarct zone
circumferential strain
MVO and IMH are independent predictors of adverse
LV remodeling and clinical outcome after STEMI [3, 4].
However, there is a conflicting evidence on the impact
of MVO and IMH on regional strain recovery [10, 12,
13]. Kidambi et al [10] demonstrated an improvement in
infarct zone circumferential strain with myocardial tag-
ging between day 2 and day 90 after STEMI in the pres-
ence of MVO or IMH. The changes were largely driven
by the recovery of epicardial strain (P = 0.03 in the pres-
ence of MVO and IMH, P < 0.01 in the presence of
MVO alone), while mid-myocardial and endocardial
strain recovery was attenuated (P ≥ 0.05). Moreover,
O’Regan et al [12] demonstrated a modest improvement
of circumferential strain with myocardial tagging in seg-
ments with MVO between day 3 and 1 year after STEMI
(− 8.1 ± 0.8% and − 14.1 ± 1.0%, respectively; P = 0.003).
On the other hand, Neizel et al [13] have demonstrated
no segmental circumferential strain recovery in the pres-
ence of MVO between 3 days and 6months after STEMI
(P = 0.2). In our study, the infarct zone circumferential
strain was significantly more impaired in patients with
MVO or IMH, both at 1 week and 6months after
STEMI, however, it improved between the two time
points regardless of the presence of MVO or IMH.
These data indicate the complexity of the healing pro-
cesses in the infarcted myocardium. Histopathological
studies have shown that early infarct tissue consists of a
necrotic core, hemorrhage, acute inflammation and
islands of tissue repair [26]. These zones often have ir-
regular and patchy distributions and are not confined to
the radial location (inner, middle, or outer third) within
Table 3 The effect of intramyocardial hemorrhage (IMH) on infarct and remote zone strain
Infarct zone circumferential strain (%) Remote zone circumferential strain (%)
1 week 6 months MD [95% CI] P-value* 1 week 6 months MD [95% CI] P-value*
IMH (N = 81) −4.1 ± 9.4 −10.5 ± 7.8 −6.4 [−8.3 to − 4.4] < 0.001 −19.2 ± 7.7 − 19.3 ± 3.7 −0.2 [− 1.7 to 1.4] 0.852
No IMH (N = 110) − 11.9 ± 7.1 −17.4 ± 6.8 −5.5 [− 6.5 to − 4.4] < 0.001 −19.8 ± 4.0 − 19.1 ± 4.1 0.6 [− 0.1 to 1.4] 0.102
MD [95% CI] 7.8 [5.5 to 10.2] 6.9 [4.8 to 9.0] 0.6 [−1.1 to 2.3] −0.2 [− 1.3 to 0.9]
P-value† < 0.001 < 0.001 0.504 0.736
CI confidence interval, IMH intramyocardial hemorrhage, MD mean difference
*the P-values for the strain difference between 6months and 1 week
†the P-values for the strain difference between the group
Table 4 The effect of left ventricular (LV) remodeling on infarct and remote zone strain
Infarct zone circumferential strain (%) Remote zone circumferential strain (%)
1 week 6 months MD [95% CI] P-
value*
1 week 6 months MD [95% CI] P-
value*
LV remodeling (N = 52) − 7.6 ± 8.2 −12.6 ± 9.4 −5.0 [−6.6 to − 3.4] < 0.001 − 20.2 ± 3.7 −19.1 ± 3.7 1.1 [0.1 to 2.1] 0.036
No LV remodeling (N =
139)
−9.0 ± 9.3 −15.1 ± 7.3 −6.2 [− 7.4 to − 4.9] < 0.001 −19.2 ± 6.5 − 19.3 ± 4.0 0.0 [− 1.0 to 1.0] 0.991




−1.0 [− 2.8 to
0.9]
0.1 [− 1.1 to
1.4]
P-value† 0.366 0.087 0.317 0.822
CI confidence interval, LV left ventricular, MD mean difference
*the P-values for the strain difference between 6months and 1 week
†the P-values for the strain difference between the group
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the infarct [26]. We may reasonably assume that the im-
provement of infarct zone circumferential strain in pa-
tients with MVO and IMH was due to the resorption of
edema and necrotic tissue, suggesting a preserved heal-
ing capacity of the infarcted myocardium even in the
presence of adverse CMR findings.
The effect of adverse LV remodeling on remote zone
circumferential strain
Similar to the majority of previous studies [9, 11] we
have shown no differences in the evolution of remote
zone circumferential strain in the overall population, as
well as in patients divided according to the
randomization treatment, patients with MVO and IMH.
However, patients with adverse LV remodeling pre-
sented with a small, but statistically significant worsen-
ing of the remote zone circumferential strain. Bulluck
et al [27] demonstrated increased extracellular volume
fraction of the remote myocardium acutely and at 5 ± 2
months after STEMI in patients who developed adverse
LV remodeling (defined as ≥20% increase in LV end-
diastolic volume). Moreover, remote zone noncontrast
T1 mapping provided independent and incremental
prognostic information above the clinical risk factors
and traditional CMR outcome markers in STEMI pa-
tients treated by primary PCI [28]. These findings indi-
cate that LV remodeling after myocardial infarction is a
complex and multifactorial process that may involve ex-
cessive inflammation/fibrosis of the remote myocardium
and may result in impaired circumferential strain.
Limitations
Feature-tracking is a novel CMR technique to assess LV
strain. Reference values for LV strain and the agreement
between different vendors of feature-tracking software
are largely unknown [29]. Furthermore, evaluation of LV
strain was not a predefined study endpoint of the
METOCARD-CNIC trial. Of the initial 196 patients with
a LAD infarct who underwent 2 CMR studies in the
METOCARD-CNIC trial, 5 patients were excluded from
the LV strain analysis due to poor CMR cine image
quality, which may have influenced our results. However,
97% feasibility of strain assessment with feature-tracking
CMR is similar to what has been described previously
[30, 31], and excellent intra- and inter-observer reprodu-
cibility of the segmental feature-tracking strain analysis
were observed, similar or slightly better to what has been
reported in the literature [32, 33]. In the present analysis
we did not analyze regional radial and longitudinal strain
since previous studies have shown that, on the segmental
level, feature-tracking-derived circumferential strain is
the most robust and has the lowest intra- and inter-
observer variability [30, 31].
Conclusion
Regional LV circumferential strain analysis with feature-
tracking CMR has revealed several important insights on
the impact of MVO, IMH and adverse LV remodeling
on the evolution of the infarct zone and remote zone
circumferential strain. Furthermore, in patients with first
anterior STEMI treated with primary PCI long-lasting
cardioprotective effects of early intravenous metoprolol
treatment on the infarct zone strain were demonstrated.
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1186/s12968-020-00638-8.
Additional File 1. Table 1: Patients demographics, cardiovascular risk
factors, clinical status at recruitment, procedural characteristics and CMR
parameters at 1 week and 6 months after STEMI
Abbreviations
bSSFP: Balanced steady state free precession; CMR: Cardiovascular magnetic
resonance; DENSE: Displacement encoding with stimulated echoes;
IMH: Intramyocardial hemorrhage; LAD: Left anterior descending coronary
artery; LCX: left circumflex coronary artery; LGE: Late gadolinium
enhancement; LM: Left main coronary artery; LV: Left ventricle/left ventricular;
METOCARD-CNIC: Effect of Metoprolol in Cardioprotetion During an Acute
Myocardial Infarction; MVO: Microvascular obstruction; PCI: Percutaneous
coronary intervention; SENC: Strain encoded; STEMI: ST-segment elevation
myocardial infarction; STIR: Short tau inversion recovery
Acknowledgements
Dr. Podlesnikar acknowledges funding received from the European Society
of Cardiology in the form of an ESC Training Grant.
Authors’ contributions
TP Conception and design of the study; analysis and interpretation of data;
drafting of the manuscript; final approval of the manuscript submitted. GP
Analysis and interpretation of data; final approval of the manuscript submitted.
RFJ Analysis and interpretation of data; final approval of the manuscript
submitted. JMMC Analysis and interpretation of data; final approval of the
manuscript submitted. JSG Analysis and interpretation of data; final approval of
the manuscript submitted. CBD Critical revision of the manuscript for important
intellectual content; final approval of the manuscript submitted. NAM Critical
revision of the manuscript for important intellectual content; final approval of
the manuscript submitted. ZF Critical revision of the manuscript for important
intellectual content; final approval of the manuscript submitted. JJB Conception
and design of the study; analysis and interpretation of data; drafting of the
manuscript; final approval of the manuscript submitted. VF Conception and
design of the study; critical revision of the manuscript for important intellectual
content; final approval of the manuscript submitted. BI Conception and design
of the study; analysis and interpretation of data; critical revision of the
manuscript for important intellectual content; final approval of the manuscript
submitted. VD Conception and design of the study; analysis and interpretation
of data; drafting of the manuscript; final approval of the manuscript submitted.
The author (s) read an approved the final manuscript
Funding
METOCARD-CNIC trial work was partially supported by the Centro Nacional
de Investigaciones Cardiovasculares (CNIC), through CNIC Translational Grant
01–2009. Other sponsors were the Spanish Ministry of Health and Social
Policy (EC10–042), the Mutua Madrileña Foundation (AP8695–2011), and a
Master Research Agreement (MRA) between Philips healthcare and the CNIC.
BI is recipient of the ISCIII Fondo de Investigación Sanitaria grants and ERDF/
FEDER funds (PI16/02110, DTS17/00136, PI13/01979, SAF2015–71613-REDI)
related to this topic. The CNIC is supported by the Ministerio de Ciencia,
Innovación y Universidades (MICINN) and the Pro CNIC Foundation, and is a
Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505). CBD is
supported by the Bristol National Institute of Health Research (NIHR)
Podlesnikar et al. Journal of Cardiovascular Magnetic Resonance           (2020) 22:44 Page 10 of 12
Biomedical Research Centre (BRC). The views expressed are those of the au-
thors and not necessarily those of the National Health Service, NIHR or De-
partment of Health. The department of Cardiology of the Leiden University
Medical Center received unrestricted research grants from Biotronik, Medtro-
nic, Boston Scientific and Edwards Lifesciences.
Availability of data and materials
The datasets used and analyzed during the current study are available from
the corresponding author on reasonable request.
Ethics approval and consent to participate
The study was approved by the ethical committees and institutional review





JSG is a Philips Healthcare employee. CBD is a consultant for Circle
Cardiovascular Imaging. VD and JJB received speaker fees from Abbott
Vascular. The remaining authors have nothing to disclose.
Author details
1Department of Cardiology, Heart Lung Center, Leiden University Medical
Center, Albinusdreef 2, 2333, ZA, Leiden, The Netherlands. 2Department of
Cardiac Surgery, University Medical Centre Maribor, Maribor, Slovenia.
3Internal Medicine Clinic, University Medical Centre Ljubljana, Ljubljana,
Slovenia. 4Centro Nacional de Investigaciones Cardiovasculares (CNIC),
Madrid, Spain. 5CIBER de enfermedades CardioVasculares (CIBERCV), Madrid,
Spain. 6Ruber Juan Bravo Hospital Universidad Europea, Madrid, Spain. 7Zena
and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at
Mount Sinai, New York City, NY, USA. 8Faculty of Medicine University of
Maribor, Maribor, Slovenia. 9Philips Healthcare, Madrid, Spain. 10Bristol Heart
Institute, Bristol NIHR Cardiovascular Research Centre, University of Bristol
and University Hospitals Bristol NHS Trust, Bristol, UK. 11IIS-Fundación Jiménez
Díaz University Hospital, Madrid, Spain.
Received: 25 November 2019 Accepted: 15 May 2020
References
1. Bulluck H, Dharmakumar R, Arai AE, Berry C, Hausenloy DJ. Cardiovascular
magnetic resonance in acute ST-segment-elevation myocardial infarction:
recent advances, controversies, and future directions. Circulation. 2018;137:
1949–64.
2. Hombach V, Grebe O, Merkle N, Waldenmaier S, Hoher M, Kochs M, et al.
Sequelae of acute myocardial infarction regarding cardiac structure and
function and their prognostic significance as assessed by magnetic
resonance imaging. Eur Heart J. 2005;26:549–57.
3. Eitel I, de Waha S, Wohrle J, Fuernau G, Lurz P, Pauschinger M, et al.
Comprehensive prognosis assessment by CMR imaging after ST-segment
elevation myocardial infarction. J Am Coll Cardiol. 2014;64:1217–26.
4. Ganame J, Messalli G, Dymarkowski S, Rademakers FE, Desmet W, Van de
Werf F, et al. Impact of myocardial haemorrhage on left ventricular function
and remodelling in patients with reperfused acute myocardial infarction. Eur
Heart J. 2009;30:1440–9.
5. Pedrizzetti G, Claus P, Kilner PJ, Nagel E. Principles of cardiovascular
magnetic resonance feature tracking and echocardiographic speckle
tracking for informed clinical use. J Cardiovasc Magn Reson. 2016;18:51.
6. Schuster A, Hor KN, Kowallick JT, Beerbaum P, Kutty S. Cardiovascular
magnetic resonance myocardial feature tracking: concepts and clinical
applications. Circ Cardiovasc Imaging. 2016;9:e004077.
7. Eitel I, Stiermaier T, Lange T, Rommel KP, Koschalka A, Kowallick JT, et al.
Cardiac magnetic resonance myocardial feature tracking for optimized
prediction of cardiovascular events following myocardial infarction. JACC
Cardiovasc Imaging. 2018;11:1433–44.
8. Gavara J, Rodriguez-Palomares JF, Valente F, Monmeneu JV, Lopez-Lereu
MP, Bonanad C, et al. Prognostic value of strain by tissue tracking cardiac
magnetic resonance after ST-segment elevation myocardial infarction. JACC
Cardiovasc Imaging. 2018;11:1448–57.
9. Kidambi A, Mather AN, Swoboda P, Motwani M, Fairbairn TA, Greenwood
JP, et al. Relationship between myocardial edema and regional myocardial
function after reperfused acute myocardial infarction: an MR imaging study.
Radiology. 2013;267:701–8.
10. Kidambi A, Mather AN, Motwani M, Swoboda P, Uddin A, Greenwood JP,
et al. The effect of microvascular obstruction and intramyocardial
hemorrhage on contractile recovery in reperfused myocardial infarction:
insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson.
2013;15:58.
11. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JA. Accuracy of contrast-
enhanced magnetic resonance imaging in predicting improvement of
regional myocardial function in patients after acute myocardial infarction.
Circulation. 2002;106:1083–9.
12. O'Regan DP, Ariff B, Baksi AJ, Gordon F, Durighel G, Cook SA. Salvage
assessment with cardiac MRI following acute myocardial infarction
underestimates potential for recovery of systolic strain. Eur Radiol. 2013;23:
1210–7.
13. Neizel M, Korosoglou G, Lossnitzer D, Kuhl H, Hoffmann R, Ocklenburg C,
et al. Impact of systolic and diastolic deformation indexes assessed by
strain-encoded imaging to predict persistent severe myocardial dysfunction
in patients after acute myocardial infarction at follow-up. J Am Coll Cardiol.
2010;56:1056–62.
14. Mangion K, Carrick D, Clerfond G, Rush C, McComb C, Oldroyd KG,
et al. Predictors of segmental myocardial functional recovery in patients
after an acute ST-elevation myocardial infarction. Eur J Radiol. 2019;112:
121–9.
15. Khan JN, Nazir SA, Singh A, Shetye A, Lai FY, Peebles C, et al. Relationship of
myocardial strain and markers of myocardial injury to predict segmental
recovery after acute ST-segment-elevation myocardial infarction. Circ
Cardiovasc Imaging. 2016;9.
16. Ibanez B, Macaya C, Sanchez-Brunete V, Pizarro G, Fernandez-Friera L,
Mateos A, et al. Effect of early metoprolol on infarct size in ST-segment-
elevation myocardial infarction patients undergoing primary percutaneous
coronary intervention: the effect of Metoprolol in Cardioprotection during
an acute myocardial infarction (METOCARD-CNIC) trial. Circulation. 2013;128:
1495–503.
17. Pizarro G, Fernandez-Friera L, Fuster V, Fernandez-Jimenez R, Garcia-Ruiz JM,
Garcia-Alvarez A, et al. Long-term benefit of early pre-reperfusion
metoprolol administration in patients with acute myocardial infarction:
results from the METOCARD-CNIC trial (effect of Metoprolol in
Cardioprotection during an acute myocardial infarction). J Am Coll Cardiol.
2014;63:2356–62.
18. Podlesnikar T, Pizarro G, Fernandez-Jimenez R, Montero-Cabezas JM,
Sanchez-Gonzalez J, Bucciarelli-Ducci C, et al. Effect of early Metoprolol
during ST-segment elevation myocardial infarction on left ventricular strain:
feature-tracking cardiovascular magnetic resonance substudy from the
METOCARD-CNIC trial. JACC Cardiovasc Imaging. 2019;12:1188–98.
19. Ibanez B, Fuster V, Macaya C, Sanchez-Brunete V, Pizarro G, Lopez-Romero P,
et al. Study design for the "effect of METOprolol in CARDioproteCtioN
during an acute myocardial InfarCtion" (METOCARD-CNIC): a randomized,
controlled parallel-group, observer-blinded clinical trial of early pre-
reperfusion metoprolol administration in ST-segment elevation myocardial
infarction. Am Heart J. 2012;164:473–80 e5.
20. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al.
Recommendations for cardiac chamber quantification by echocardiography
in adults: an update from the American Society of Echocardiography and
the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc
Imaging. 2015;16:233–70.
21. Ortiz-Perez JT, Rodriguez J, Meyers SN, Lee DC, Davidson C, Wu E.
Correspondence between the 17-segment model and coronary arterial
anatomy using contrast-enhanced cardiac magnetic resonance imaging.
JACC Cardiovasc Imaging. 2008;1:282–93.
22. Pereztol-Valdes O, Candell-Riera J, Santana-Boado C, Angel J, Aguade-Bruix
S, Castell-Conesa J, et al. Correspondence between left ventricular 17
myocardial segments and coronary arteries. Eur Heart J. 2005;26:2637–43.
23. Cerci RJ, Arbab-Zadeh A, George RT, Miller JM, Vavere AL, Mehra V, et al.
Aligning coronary anatomy and myocardial perfusion territories: an
algorithm for the CORE320 multicenter study. Circ Cardiovasc Imaging.
2012;5:587–95.
24. Joyce E, Hoogslag GE, Leong DP, Debonnaire P, Katsanos S, Boden H, et al.
Association between left ventricular global longitudinal strain and adverse
Podlesnikar et al. Journal of Cardiovascular Magnetic Resonance           (2020) 22:44 Page 11 of 12
left ventricular dilatation after ST-segment-elevation myocardial infarction.
Circ Cardiovasc Imaging. 2014;7:74–81.
25. Fernandez-Jimenez R, Barreiro-Perez M, Martin-Garcia A, Sanchez-Gonzalez J,
Aguero J, Galan-Arriola C, et al. Dynamic edematous response of the human
heart to myocardial infarction: implications for assessing myocardial area at
risk and salvage. Circulation. 2017;136:1288–300.
26. Reimer KA, Jennings RB. The changing anatomic reference base of evolving
myocardial infarction. Underestimation of myocardial collateral blood flow
and overestimation of experimental anatomic infarct size due to tissue
edema, hemorrhage and acute inflammation. Circulation. 1979;60:866–76.
27. Bulluck H, Rosmini S, Abdel-Gadir A, White SK, Bhuva AN, Treibel TA, et al.
Automated extracellular volume fraction mapping provides insights into the
pathophysiology of left ventricular remodeling post-Reperfused ST-elevation
myocardial infarction. J Am Heart Assoc. 2016;5.
28. Reinstadler SJ, Stiermaier T, Liebetrau J, Fuernau G, Eitel C, de Waha S, et al.
Prognostic significance of remote myocardium alterations assessed by
quantitative noncontrast T1 mapping in ST-segment elevation myocardial
infarction. JACC Cardiovasc Imaging. 2018;11:411–9.
29. Claus P, Omar AM, Pedrizzetti G, Sengupta PP, Nagel E. Tissue tracking
Technology for Assessing Cardiac Mechanics: principles, Normal values, and
clinical applications. JACC Cardiovasc Imaging. 2015;8:1444–60.
30. Augustine D, Lewandowski AJ, Lazdam M, Rai A, Francis J, Myerson S, et al.
Global and regional left ventricular myocardial deformation measures by
magnetic resonance feature tracking in healthy volunteers: comparison with
tagging and relevance of gender. J Cardiovasc Magn Reson. 2013;15:8.
31. Andre F, Steen H, Matheis P, Westkott M, Breuninger K, Sander Y, et al. Age-
and gender-related normal left ventricular deformation assessed by
cardiovascular magnetic resonance feature tracking. J Cardiovasc Magn
Reson. 2015;17:25.
32. Wu L, Germans T, Guclu A, Heymans MW, Allaart CP, van Rossum AC.
Feature tracking compared with tissue tagging measurements of segmental
strain by cardiovascular magnetic resonance. J Cardiovasc Magn Reson.
2014;16:10.
33. Mangion K, Burke NMM, McComb C, Carrick D, Woodward R, Berry C.
Feature-tracking myocardial strain in healthy adults- a magnetic resonance
study at 3.0 tesla. Sci Rep. 2019;9:3239.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Podlesnikar et al. Journal of Cardiovascular Magnetic Resonance           (2020) 22:44 Page 12 of 12
